Barclays’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $476M | Buy |
6,084,725
+3,329,584
| +121% | +$269M | 0.09% | 145 |
|
|
2026
Q1 | $239M | Buy |
2,755,141
+514,177
| +23% | +$49.3M | 0.06% | 251 |
|
|
2025
Q4 | $215M | Sell |
2,240,964
-4,590,239
| -67% | -$446M | 0.05% | 269 |
|
|
2025
Q3 | $651M | Buy |
6,831,203
+3,492,192
| +105% | +$321M | 0.14% | 93 |
|
|
2025
Q2 | $291M | Buy |
3,339,011
+860,585
| +35% | +$73M | 0.07% | 199 |
|
|
2025
Q1 | $223M | Sell |
2,478,426
-38,509
| -2% | -$3.45M | 0.06% | 225 |
|
|
2024
Q4 | $201M | Sell |
2,516,935
-427,624
| -15% | -$37M | 0.06% | 232 |
|
|
2024
Q3 | $265M | Sell |
2,944,559
-286,725
| -9% | -$24.1M | 0.07% | 204 |
|
|
2024
Q2 | $254M | Sell |
3,231,284
-494,753
| -13% | -$40.6M | 0.08% | 187 |
|
|
2024
Q1 | $325M | Buy |
3,726,037
+211,726
| +6% | +$18.1M | 0.11% | 151 |
|
|
2023
Q4 | $290M | Buy |
3,514,311
+64,811
| +2% | +$4.94M | 0.11% | 169 |
|
|
2023
Q3 | $270M | Buy |
3,449,500
+520,705
| +18% | +$43.6M | 0.17% | 129 |
|
|
2023
Q2 | $258M | Buy |
2,928,795
+1,296,065
| +79% | +$112M | 0.16% | 125 |
|
|
2023
Q1 | $132M | Sell |
1,632,730
-4,186,727
| -72% | -$341M | 0.06% | 209 |
|
|
2022
Q4 | $452M | Sell |
5,819,457
-1,277,920
| -18% | -$104M | 0.2% | 71 |
|
|
2022
Q3 | $573M | Sell |
7,097,377
-2,980,474
| -30% | -$268M | 0.63% | 19 |
|
|
2022
Q2 | $904M | Buy |
10,077,851
+4,270,657
| +74% | +$433M | 0.55% | 22 |
|
|
2022
Q1 | $644M | Sell |
5,807,194
-781,700
| -12% | -$82.6M | 0.5% | 30 |
|
|
2021
Q4 | $682M | Buy |
6,588,894
+1,937,158
| +42% | +$224M | 0.25% | 70 |
|
|
2021
Q3 | $583M | Buy |
4,651,736
+796,827
| +21% | +$103M | 0.26% | 62 |
|
|
2021
Q2 | $479M | Buy |
3,854,909
+445,618
| +13% | +$56M | 0.23% | 62 |
|
|
2021
Q1 | $403M | Buy |
3,409,291
+401,049
| +13% | +$47M | 0.22% | 67 |
|
|
2020
Q4 | $352M | Sell |
3,008,242
-614,745
| -17% | -$67.7M | 0.19% | 81 |
|
|
2020
Q3 | $377M | Buy |
3,622,987
+1,178,976
| +48% | +$118M | 0.22% | 66 |
|
|
2020
Q2 | $224M | Buy |
2,444,011
+112,626
| +5% | +$10.8M | 0.17% | 84 |
|
|
2020
Q1 | $210M | Sell |
2,331,385
-691,405
| -23% | -$73.6M | 0.17% | 86 |
|
|
2019
Q4 | $343M | Sell |
3,022,790
-77,166
| -2% | -$8.47M | 0.19% | 87 |
|
|
2019
Q3 | $337M | Sell |
3,099,956
-840,657
| -21% | -$87.7M | 0.21% | 80 |
|
|
2019
Q2 | $384M | Buy |
3,940,613
+791,537
| +25% | +$72.3M | 0.24% | 68 |
|
|
2019
Q1 | $287M | Sell |
3,149,076
-43,523
| -1% | -$3.9M | 0.2% | 72 |
|
|
2018
Q4 | $290M | Sell |
3,192,599
-153,097
| -5% | -$14.3M | 0.22% | 66 |
|
|
2018
Q3 | $329M | Sell |
3,345,696
-167,559
| -5% | -$15.5M | 0.23% | 66 |
|
|
2018
Q2 | $301M | Sell |
3,513,255
-1,006,959
| -22% | -$84.1M | 0.26% | 56 |
|
|
2018
Q1 | $363M | Buy |
4,520,214
+855,053
| +23% | +$70.5M | 0.28% | 67 |
|
|
2017
Q4 | $296M | Buy |
3,665,161
+1,334,397
| +57% | +$107M | 0.24% | 74 |
|
|
2017
Q3 | $181M | Buy |
2,330,764
+190,435
| +9% | +$15.8M | 0.19% | 87 |
|
|
2017
Q2 | $190M | Buy |
2,140,329
+51,686
| +2% | +$4.36M | 0.2% | 65 |
|
|
2017
Q1 | $168M | Buy |
2,088,643
+581,091
| +39% | +$45.4M | 0.18% | 82 |
|
|
2016
Q4 | $107M | Sell |
1,507,552
-696,185
| -32% | -$54.7M | 0.12% | 139 |
|
|
2016
Q3 | $190M | Sell |
2,203,737
-281,133
| -11% | -$24.5M | 0.21% | 60 |
|
|
2016
Q2 | $216M | Sell |
2,484,870
-247,299
| -9% | -$20M | 0.28% | 45 |
|
|
2016
Q1 | $205M | Buy |
2,732,169
+323,785
| +13% | +$24.4M | 0.31% | 43 |
|
|
2015
Q4 | $183M | Buy |
2,408,384
+930,540
| +63% | +$70M | 0.22% | 73 |
|
|
2015
Q3 | $97.5M | Sell |
1,477,844
-370,063
| -20% | -$27.3M | 0.12% | 143 |
|
|
2015
Q2 | $137M | Sell |
1,847,907
-449,391
| -20% | -$34.3M | 0.15% | 106 |
|
|
2015
Q1 | $177M | Buy |
2,297,298
+1,049,648
| +84% | +$79.6M | 0.2% | 73 |
|
|
2014
Q4 | $89.8M | Sell |
1,247,650
-136,418
| -10% | -$9.48M | 0.09% | 187 |
|
|
2014
Q3 | $84.4M | Buy |
1,384,068
+343,139
| +33% | +$21.8M | 0.08% | 192 |
|
|
2014
Q2 | $65.6M | Sell |
1,040,929
-51,003
| -5% | -$3.1M | 0.07% | 238 |
|
|
2014
Q1 | $66.6M | Buy |
1,091,932
+59,005
| +6% | +$3.44M | 0.08% | 231 |
|
|
2013
Q4 | $58.9M | Buy |
1,032,927
+82,069
| +9% | +$4.65M | 0.06% | 289 |
|
|
2013
Q3 | $50.4M | Buy |
950,858
+63,431
| +7% | +$3.41M | 0.06% | 294 |
|
|
2013
Q2 | $45.7M | Buy |
+887,427
| New | +$43.9M | 0.06% | 285 |
|
Other funds holding MDT
Barclays's MDT Position: Q2 2026 in Review
Barclays increased its Medtronic (MDT) stake by 121% in Q2 2026, buying an estimated $269M and bringing the position to 6,084,725 shares worth $476M. The position accounts for 0.09% of the portfolio, ranked #145.
Barclays first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $904M in Q2 2022. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Barclays held 6,084,725 shares of Medtronic worth $476M as of Q2 2026.
- Barclays bought 3,329,584 Medtronic shares in Q2 2026, an estimated $269M.
- Medtronic made up 0.09% of Barclays's portfolio in Q2 2026, its #145 holding.
- Barclays first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
- Barclays's Medtronic position peaked at $904M in Q2 2022.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.